Initial Results after Re-Irradiation in Combination with Cetuximab in the Treatment of recurrent Head and Neck Squamous

被引:0
|
作者
Balermpas, P. [1 ]
Weiss, C. [1 ]
Roedel, C. [1 ]
机构
[1] Klinikum JW Goethe Univ, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:28 / 28
页数:1
相关论文
共 50 条
  • [31] Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer
    Salama, Joseph K.
    Vokes, Everett E.
    SEMINARS IN ONCOLOGY, 2008, 35 (03) : 251 - 261
  • [32] Fast tumour re-growth of head and neck cancer (HNC) after compassionate treatment (CTr) with re-irradiation, carboplatin and concurrent cetuximab
    Merlano, M
    Colantonio, I
    Numico, G
    Vigna-Taglianti, R
    Lanzilotta, L
    ANNALS OF ONCOLOGY, 2005, 16 : 298 - 298
  • [33] Outcome after Re-Irradiation of Head and Neck Cancer Patients
    Platteaux, Nele
    Dirix, Piet
    Vanstraelen, Bianca
    Nuyts, Sandra
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (01) : 23 - 31
  • [34] Phase 2 Trial of Continuous Course Re-irradiation Concurrent With Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Preliminary Report
    Yao, M.
    Wang, D.
    Sumer, B. D.
    Larry, M.
    Truelson, J.
    Randall, H.
    Wong, S.
    Lavertu, P.
    Yordy, J.
    Smith, I.
    Nedzi, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S179 - S179
  • [35] Reply to: Comment on Dornoff et al.: re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck
    Balermpas, Panagiotis
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (12) : 986 - 986
  • [36] Reply to: Comment on Dornoff et al.: re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck
    Panagiotis Balermpas
    Strahlentherapie und Onkologie, 2015, 191 : 986 - 986
  • [37] Toxicity of Continuous Course Re-irradiation Concurrent With Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Report of a Phase 2 Trial
    Nedzi, L. A.
    Yao, M.
    Wang, D.
    Sumer, B.
    Hughes, R.
    Lavartu, P.
    Wong, S.
    Myers, L.
    Yordy, J.
    Truelson, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S58 - S58
  • [38] Patterns of Failure After IMRT and Proton Re-Irradiation for Patients With Recurrent Head and Neck Cancer
    Ng, S. P.
    Martin, G. V.
    Guha-Thakurta, N.
    Wang, H.
    Pollard, C., III
    Bahig, H.
    Meheissen, M. A. M.
    Nguyen, T. P.
    Mohamed, A. S.
    Fuller, C. D.
    Garden, A. S.
    Frank, S. J.
    Gunn, G. B.
    Reddy, J.
    Morrison, W. H.
    Moreno, A. C.
    Phan, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E375 - E375
  • [39] Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review
    Svajdova, Michaela
    Dubinsky, Pavol
    Kazda, Tomas
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (01): : 354 - 366
  • [40] Re-irradiation with curative intent of squamous cell carcinomas of the head and neck in Denmark
    Engelmann, B. E.
    Andersen, M.
    Elmann, C.
    Farhadi, M.
    Gothelf, A.
    Hansen, C. R.
    Nowicka-Matus, K.
    Petersen, J. B. B.
    Samsoe, E.
    Sand, H. M.
    Smulders, B.
    Johansen, J.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 23 - 23